| 1. | alein99 | |
| 2. | dddimensions | |
| 3. | jjhale69 | |
| 4. | robflutie | |
| 5. | jakuwladi |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | alein99 01/22/2018 $85 million of its common stock |
| 2. | robflutie 10/01/2017 Noble Financial resumes at Buy. When the company releases positive phase 2b results on MS study, the stock is heading up to the next level. They are trying to bore us right now... |
| 3. | dddimensions 10/01/2017 I think this drug has a good chance to make it. EMERYVILLE, Calif., Sept. 07, 2017-- Adamas Pharmaceuticals, Inc. today announced positive topline data from the Phase 1 b clinical trial of ADS-4101 |
| 4. | jjhale69 02/08/2018 Tempting! |
| 5. | dddimensions 01/22/2018 Adamas Announces Proposed Public Offering of Common Stock |
| 6. | rodina9046 04/04/2018 Leerink Partners initiates as an outperform, $31PT |
| 7. | jjhale69 01/23/2018 Anyone seen this news? PT $48 |
| 8. | jakuwladi 02/20/2018 No anger at all...I rest well at night... this is a long term hold for me |
| 9. | jjhale69 01/26/2018 Prices 3 mln shares of common stock at $41.50 per share |
| 10. | alein99 10/01/2017 Adamas' Parkinson's Drug Cost Is Double Analyst Expectations |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Adamas Pharmaceuticals, Inc.
- ADMS
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.